5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of genetic variants in never-smokers with lung cancer facilitated by an internet-based blood collection protocol: A preliminary report
    Journal Article

    Girard, N.; Lou, E.; Azzoli, C. G.; Reddy, R.; Robson, M.; Harlan, M.; Orlow, I.; Yatabe, Y.; Nafa, K.; Ladanyi, M.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Use of epidermal growth factor receptor/kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: Comparison with clinical guidelines
    Journal Article

    Girard, N.; Deshpande, C.; Azzoli, C. G.; Rusch, V. W.; Travis, W. D.; Ladanyi, M.; Pao, W.
    Chest (2010)

    Fulltext@MSK | Save
  • Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
    Journal Article

    Figueroa, M. E.; Abdel-Wahab, O.; Lu, C.; Ward, P. S.; Patel, J.; Shih, A.; Li, Y.; Bhagwat, N.; Vasanthakumar, A.; Fernandez, H. F.; more...
    Cancer Cell (2010)

    Fulltext@MSK | Save
  • Harvesting the low-hanging fruit: Kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer
    Journal Article

    Fagin, J. A.; Tuttle, R. M.; Pfister, D. G.
    Journal of Clinical Endocrinology and Metabolism (2010)

    Fulltext@MSK | Save
  • To remain current, and to do so briefly
    Journal Article

    Fagin, J. A.
    Endocrine-Related Cancer (2010)

    Fulltext@MSK | Save
  • The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia
    Journal Article

    Espinosa, L.; Cathelin, S.; D'Altri, T.; Trimarchi, T.; Statnikov, A.; Guiu, J.; Rodilla, V.; Inglés-Esteve, J.; Nomdedeu, J.; Bellosillo, B.; more...
    Cancer Cell (2010)

    Fulltext@MSK | Save
  • Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)
    Journal Article

    Dry, J. R.; Pavey, S.; Pratilas, C. A.; Harbron, C.; Runswick, S.; Hodgson, D.; Chresta, C.; McCormack, R.; Byrne, N.; Cockerill, M.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation
    Journal Article

    Cohen, A. D.; Schaer, D. A.; Liu, C.; Li, Y.; Hirschhorn-Cymmerman, D. ; Kim, S. C.; Diab, A.; Rizzuto, G.; Duan, F.; Perales, M. A.; more...
    PLoS ONE (2010)

    Fulltext@MSK | Save
  • ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
    Journal Article

    Chi, P.; Chen, Y.; Zhang, L.; Guo, X.; Wongvipat, J.; Shamu, T.; Fletcher, J. A.; Dewell, S.; Maki, R. G.; Zheng, D.; more...
    Nature (2010)

    Fulltext@MSK | Save
  • Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers
    Journal Article

    Chi, P.; Allis, C. D.; Wang, G. G.
    Nature Reviews Cancer (2010)

    Fulltext@MSK | Save